Myocardial Infarction As the Initial Presentation of Rituximab-Induced Interstitial Lung Disease: A Case Report

Rituximab has been widely used alone or in combination therapy to treat B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, and various autoimmune diseases. Although it is a relatively safe drug, rare rituximab-induced interstitial lung disease (RTX-ILD) has been reported and can be potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Mohamed, Khan, Arshan A, El Kortbi, Khadija, Wang, Hayoung, Wang, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482808/
https://www.ncbi.nlm.nih.gov/pubmed/36148180
http://dx.doi.org/10.7759/cureus.28179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482808/
https://www.ncbi.nlm.nih.gov/pubmed/36148180
http://dx.doi.org/10.7759/cureus.28179

Ejemplares similares